Cleanroom ISO Classification: The Framework For Containment In A Cleanroom

Cleanroom ISO classification decisions sit at the intersection of facility design, manufacturing performance, and regulatory success. In advanced biotech and pharmaceutical environments—particularly cell and gene therapy, viral vector, mRNA, API, and sterile ATMP manufacturing—those decisions carry added weight as teams balance product protection, containment, and operator safety. ISO classification strategy directly influences critical design elements, including process layout, HVAC architecture, air change rates, pressurization schemes, and airlock sequencing in BSL- and OEB-driven environments. Early alignment between process operations, containment strategy, and regulatory expectations is essential when working with biohazardous materials, high-potency compounds, and patient-specific therapies.

Misaligned classification decisions can drive costly redesigns, limit manufacturing flexibility, and increase operator exposure risk. Examine how integrating ISO classification into early design phases strengthens containment, supports inspection readiness, and enables safe, scalable ATMP manufacturing operations.